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Abstract
We provide an assessment of the impact of government closure and containment measures
on deaths from COVID-19 across sequential waves of the COVID-19 pandemic globally.
Daily data was collected on a range of containment and closure policies for 186 countries
from January 1, 2020 until March 11th, 2021. These data were combined into an aggregate
stringency index (SI) score for each country on each day (range: 0–100). Countries were
divided into successive waves via a mathematical algorithm to identify peaks and troughs of
disease. Within our period of analysis, 63 countries experienced at least one wave, 40 coun-
tries experienced two waves, and 10 countries saw three waves, as defined by our
approach. Within each wave, regression was used to assess the relationship between the
strength of government stringency and subsequent deaths related to COVID-19 with a num-
ber of controls for time and country-specific demographic, health system, and economic
characteristics. Across the full period of our analysis and 113 countries, an increase of 10
points on the SI was linked to 6 percentage points (P < 0.001, 95% CI = [5%, 7%]) lower
average daily deaths. In the first wave, in countries that ultimately experiences 3 waves of
the pandemic to date, ten additional points on the SI resulted in lower average daily deaths
by 21 percentage points (P < .001, 95% CI = [8%, 16%]). This effect was sustained in the
third wave with reductions in deaths of 28 percentage points (P < .001, 95% CI = [13%,
21%]). Moreover, interaction effects show that government policies were effective in reduc-
ing deaths in all waves in all groups of countries. These findings highlight the enduring
importance of non-pharmaceutical responses to COVID-19 over time.
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Introduction
The COVID-19 pandemic has upended healthcare, cultural, financial, and government sys-
tems worldwide. While vaccines are being deployed rapidly one year after the outbreak began,
control of the COVID-19 pandemic continues to rely largely on government non-pharmaceu-
tical interventions (NPIs) [1–6]. Such interventions have proliferated worldwide, including
school closings, travel restrictions, public gathering bans, and stay-at-home orders [7]. These
policies aim to create physical distancing or otherwise slow the spread of COVID-19, often in
concert with testing and contact tracing regimes of varying robustness [3, 8–11]. In some
cases, closure and containment measures have been extreme, with unprecedented social, cul-
tural, and financial implications [12–14]. Governments have varied significantly in both the
degree of their interventions and how quickly they adopt them [15, 16].
Robust evidence now shows that, under most conditions, early adoption of stringent NPIs
is associated with a reduction in transmission [16–27]. However, with full vaccination still elu-
sive, and with the possibility of vaccine-escaping variants emerging, NPIs can be expected to
continue playing a significant role in managing the pandemic in the foreseeable future [28–
31]. A critical question is therefore whether we can expect NPIs to continue working as the
pandemic stretches into longer time frames. On the one hand, we might expect effectiveness to
improve over time as governments learn how to better calibrate and target policies [32, 33].
On the other hand, we may expect the opposite to the extent individuals grow tired of
COVID-19 restrictions, as responses become politicized, or as economic disruption grows
more severe [34–39].
As a first step toward investigating these trends, we explore the average effects of NPIs on
the spread of the disease globally. We present a global analysis of governments’ responses to
date, and a global assessment of their relationship to the spread of the pandemic over time. We
tracked 186 governments’ responses across a series of non-pharmaceutical interventions and
created a composite index that captured how, over time, each country’s government
responded. Looking at peaks and troughs in countries’ death tolls, we divide each outbreak
into successive waves, limiting our analysis to the 113 countries that recorded at least one
death per day, on average, in the period of analysis. We hypothesized that the overall strin-
gency of governments’ interventions would affect the subsequent rate of deaths related to
COVID-19 in each wave, comparing the effects of policies and deaths both across countries
and across waves. This article seeks to make three contributions. First, we explore whether the
effects of policies on deaths varies across each wave of the pandemic. Second, we develop an
approach to operationalize in observational analysis an approach to variation in the effect of
policy over time, a feature of some epidemiological models [40]. Third, our analysis includes a
global distribution of countries experiencing significant outbreaks of COVID-19.
Methods
Data collection
We collected information on 186 national governments’ responses across a range of NPIs (see
S1 Table in S1 File). These measures were recorded for each day in each country, creating a
measure of variation in government responses both across countries and across time. Data
were collected by the authors and trained research assistants from publicly available sources
such as news articles, government briefings, and international organizations. Data collectors
coded government responses on a simple binary or ordinal scale registering the stringency of a
given policy. Indicators C1-C7 and H1 (see S1 Table in S1 File) were further classified as either
“targeted” (meaning they apply only in a geographically concentrated area) or “general”
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(meaning they apply throughout the entire jurisdiction). The data cover over 186 countries
from January 1, 2020 onwards, though we limit our analysis up until March 11th, 2021 and to
only the 113 countries that experienced one or more deaths per day, on average, during the
period of analysis. Because we do not use human data or tissue, or involve human subjects,
approval by the university review board was not required. To ensure accuracy and consistency,
data collectors were required to pass an online training and to participate in regular team
review meetings. Each data point was verified by at least two data collectors independently,
and includes notes and source materials to substantiate each observation. Importantly, for all
NPIs, we record only the official policies at the national level, not how well they are imple-
mented or enforced.
Measuring government non-pharmaceutical interventions
Our primary measure of governments’ NPIs is a composite Stringency Index (SI) that records
the number and restrictiveness of government containment and closure measures, calculated
as follows. For each of the nine relevant policy response indicators, we create a score by taking
the ordinal value, adding 0.5 if the policy is general rather than targeted, and rescaling each of
these to range from 0–100. Conservatively, we assign a score of 0 to any indicators missing
data, and reject any country-days where more than one of the indicators is missing. The mean
of these nine scores gives the composite SI.
We rely chiefly on this simple, unweighted SI because this approach is most transparent
and easiest to interpret [41]. Composite indices have the value of facilitating comparison across
countries, albeit with the trade-off of condensing information. In practice, however, we
observe that most countries in the time period of analysis adopted most NPIs as a package, fur-
ther justifying the use of a composite measure [7]. The robustness of SI is also supported by
the high correlations between this and alternative indexes in both level of stringency and shifts
over time [42].
The degree of government response is measured by the value of the SI for a country on a
particular day, or, in the cross-sectional analyses, the average level of stringency from January
1, 2020 to March 11th, 2021.
In addition to the nine indicators that comprise the stringency index, we include as a con-
trol measures of governments’ testing and contact tracing (S1 Table in S1 File). This controls
for the potential that effects on deaths are confounded with increased identification of
COVID-19 cases and deaths. These are also recorded on an ordinal scale representing the
breadth and thoroughness of the policy. Additionally, we use an additional index, the govern-
ment response index, as a robustness measure. The government response index consolidates
an expanded set of indicators, including, for example, economic support and vaccination
policies.
Dividing countries into outbreak weaves
We identify each country’s respective outbreak “waves.” Accounting for specific waves is criti-
cal. First, this is important to answer the question of whether the effectiveness of government
policies is sustained over time and across different phases of the pandemic. Second, accounting
for waves has a methodological advantage of enabling more precise calibration to the specific
slope of the curve in each wave, rather than applying a one-size-fits-all estimation technique
across all waves. Even within a country, waves often have substantially different peaks, troughs,
and slopes.
Studies on COVID-19 and the previous ten virus-driven pandemics since 1889 have found
similar wave patterns [43, 44]. There is no scientific agreement on the definition of a “wave”,
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or on the question of whether the driving force of this pattern is human behaviour or the
spread of the virus [45, 46]. Yet, the literature includes various models to predict future waves,
and some studies elaborate different time-variant associations between the spread of the virus
and non-epidemic dynamics such as human behaviour, government measures and enforce-
ment, as well as environmental factors, such as temperature [33, 47–51]. Some studies find
COVID-19 waves can share characteristics, such as the vulnerability of the elderly population;
others find the demographic structure of cases and deaths shift substantially across waves [52,
53]. Researchers have also found that different waves in a single country may be dominated by
clusters and outbreaks in dispersed locations [54].
While the literature does not offer a precise definition of “waves”, there is a broad consensus
that a wave is a phase of disease that is more substantial than a “sporadic outbreak”, and that
comprises a rising phase and a subsequent falling phase [46, 55]. As a first step in identifying
waves, we therefore locate peaks and troughs for each wave in each country and split waves
between troughs accordingly. We smooth curves using a local non-parametric polynomial
regression, a generalized form of a moving average, to avoid misidentification of waves due to
noisy data or fluctuation in reporting of deaths. Specifically, we use locally weighted scatterplot
smoothing, also known as LOWESS regression. We identify waves as the point before and
after troughs. We consider waves distinct if their troughs are more than approximately one
month apart, otherwise we include this together as one wave. We chose this threshold to corre-
spond to the lag we hypothesize between NPIs and deaths, discussed below. In addition, we
only count a wave if more than 20 cases occurred in that given wave (to distinguish a wave
from a sporadic outbreak). Given the lack of consensus in the literature on how to define a
wave, we believe the approach selected is transparent and simple, facilitating analysis, but we
do not claim it is the only or best way to divide the phases of the pandemic. Finally, we con-
sider the period from early January 2020 to March 11th, 2021. Since then, additional waves
have emerged in multiple countries, however, these waves are ongoing and the effects of poli-
cies on deaths during these waves are not yet able to be fully detected.
For example, Fig 1 below shows peaks and troughs in India, South Africa, and the United
States and. As of March 2021, India has one major and extended wave from April 2021-Janu-
ary 2022; South Africa had 2 waves: the first in July-September, and the second in December-
February; and the United States had 3 waves: the first in April-May, the second in July-August,
and the third in December-February. These examples clearly highlight the need to take a data-
driven approach to identifying waves. Waves occur in different countries at different points in
time, and last for different lengths of time. Moreover, a standardized approach is needed to
draw boundaries between waves and sporadic outbreaks or “noisy” data. Our approach is cer-
tainly not the only way to identify waves, but provides a useful tool to facilitate analysis of the
effect of NPIs.
Outcome variables
We estimate the relationship between government interventions and the intensity of the
COVID-19 outbreak by country. Information on confirmed COVID-19 cases and deaths were
taken from John Hopkins University [56]. However, the true number of cases and deaths, as
well as the reproduction number, are the subjects of significant uncertainty and a major topic
of ongoing research [12, 57–59]. Observationally, the true number of cases is difficult to mea-
sure consistently because different countries have tested for COVID-19 more or less widely,
and report case information in variable ways [3, 60]. We take a conservative approach and use
recorded deaths as our main outcome, which we expect to be reported more consistently and
captures the public health consequence of the epidemic most directly.
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We analyse deaths in terms of the daily natural log in deaths in a country. We use the log
transformation to account for the exponential trajectory of the epidemic growth curve. This
specification also facilitates analysis because the first differences in logs approximate percent-
age changes, meaning the coefficients from our regressions are readily interpretable.
Statistical analysis
Our approach aligns with well-established empirical methods to study how government mea-
sures address historical epidemics and during the COVID-19 pandemic [61, 62]. We estimate
how the degree of government response relates to changes in deaths using Ordinary Least
Squares (OLS) regression, with the country-day as the unit of analysis. We include country
fixed effects to control for variations in country-specific factors. To this end, effects of policies
are estimated based on within country changes in deaths for 113 countries [63]. Importantly,
country fixed effects control for all country-specific characteristics that do not vary over the
period of analysis, such as the level of wealth, pre-existing robustness of the health care system,
the government’s overall capacity to implement policy, or the population’s general tendency to
follow government advice or not. We also control for deaths at the beginning of the time
period of analysis to account for variations in baseline deaths in a given country and wave. As
a robustness check to ensure county fixed effects models are not biased, we also estimate
Fig 1. Identifying waves of COVID-19 in different countries. India, South Africa, and the United States exemplify the need for data-driven distinctions for
enumerating waves, which occurred in different months, to different degrees and over different time horizons.
https://doi.org/10.1371/journal.pone.0253116.g001
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models that directly include controls for country-specific factors using data from the World
Bank; these controls include adult mortality rates, hospital bed per 1000 people, number of
physicians per 1000 people, prevalence of diabetes, population density, total population, and
GDP per capita. Additional robustness checks use subnational jurisdictions in countries with
substantial policy heterogeneity, such as the United States and Brazil. We also include robust-
ness tests with an alternative index, the Government Response Index, as well as including con-
trols for testing and contact tracing policies.
We estimate these models across all country-days during the entire period of analysis from
January 2020 to March 11th 2021. We include countries with at least one death per day on aver-
age over this period. Since effects are identified based on within country changes in deaths,
countries that had very few deaths will not have enough variation to enable a credible analysis.
If we did not include country fixed effects, identification would also be derived from across-
country differences in policy and resulting deaths. However, we avoid this estimation
approach since it introduces bias in the form of confounded variables such as wealth, age-
structure, and health care capacity variation across countries. 113 countries are included in the
final sample. We estimate wave-specific effects using interaction terms for each wave, inter-
acted with the stringency index.
This kind of observational study faces two key inferential challenges: how to control for the
effect of time, including the “natural” growth and diminishing of the disease, which is unob-
served, as well as the possibility of reverse causality or other forms of endogeneity. For exam-
ple, a positive relationship between current stringency and new deaths does not necessarily
mean stringency increases deaths; rather deaths might trigger a policy response. We address
these issues in three ways.
First, we lag the explanatory variable by four weeks. This period reflects our best estimate,
based on the existing literature, of the lag between behavioural change, transmission, the emer-
gence of disease, and, ultimately, death. Studies find that NPIs significantly reduces the repro-
duction number of SARS-CoV-2 in the subsequent 28 days after introducing the policies,
provided public events are banned throughout [64]. However, the event of introducing a lock-
down contributes very little to mitigating a pandemic wave after 30 days [65]. Second, we use
log of deaths as the dependent variable, approximating the exponential growth rate of the epi-
demiological curve. Third, we include a time trend in regressions to account for natural
growth patterns in deaths as well as normalize the time period to account for the time in which
the epidemic reached different countries across the globe. With this specification, which is
now common in the literature, we identify likely effects of NPIs on the number of deaths from
COVID-19. However, we suggest a modest interpretation of causality given the inherent chal-
lenges of identification for this research design.
Results
Variation in the speed and intensity of government responses and waves of
disease
We observed significant variation in both the level of stringency and the time at which policies
are adopted across national governments. While there is a near-universal increase in countries
adopting containment and closure measures over time, with most countries moving to strin-
gent measures after the first week of March 2020, the varied spread of the disease globally
means that some countries adopted “lockdown” measures before local transmission began and
some after. As the pandemic has progressed, countries increasingly differ in the NPIs they
adopt. While information campaigns, international travel controls, and testing and contact
measures tend to remain in place, closure and containment policies have waxed and waned7.
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We also observe variation in how many waves of disease countries experience. At the time
of writing, most countries (63) have experienced two waves, 40 have only experienced one and
10 have experienced three or more. The number of waves continues to evolve, revealing the
need for a wave-specific analysis and motivating future work on this subject. In the Supple-
ment, we include figures for a series of example country and their respective waves.
Regression results
Our core question is how NPIs, as measured by the Stringency Index, affect deaths in each
country during each wave. Table 1 presents the results. Each coefficient shows how a one point
increase in the stringency of government response four weeks prior relates to the difference in
log of daily deaths in a given country on an average day. Further models are reported in the
supplement as robustness checks (S2.1–S2.4 Tables in S1 File). Overall, the results strongly
indicate that more stringent responses led to fewer deaths. Column (1) shows that 1 point of
higher stringency 28 days in the past leads to an average reduction in deaths in all countries
across all waves of -.006 (P< 0.001, 95% CI = [-0.005, -0.007]). In countries with one wave
(column 2), we find an estimated reduction of -.005 (P < 0.001, 95% CI = [-0.003, -0.007])
with each additional point of stringency. In countries with a second wave (column 3), we find
a reduction in deaths of -.004 (P < 0.001, 95% CI = [-0.002, -0.006]) in the first wave and -.008
(P< 0.001, 95% CI = [-0.006, -0.01]) in the second wave. In countries with a third wave (col-
umn 4), we find a reduction of -.021 (P < 0.001, 95% CI = [-0.017, -0.025]) in the first wave,
-.031 (P< 0.001, 95% CI = [-0.027, -0.035]) in the second wave and -.028 (P< 0.001, 95% CI
= [-0.024, -0.032]) in the third wave. All p-values in all cases are P< .001 indicating highly sta-
tistically significant results. Since first differences in logs approximate percentage changes and
are asymptotically identical at small values, these effects can be interpreted as percentage
Table 1. Association of government response stringency and deaths by wave.
(1) (2) (3) (4)
Pooled Estimates for All Countries One-Wave Countries Two-Wave Countries Three-Wave Countries
LAGGED STRINGENCY BY 28 DAYS -0.006���
(0.001)
[0.000]
LAGGED STRINGENCY BY 28 DAYS: WAVE 1 -0.005��� -0.004��� -0.021���
(0.001) (0.001) (0.002)
[0.000] [0.000] [0.000]
LAGGED STRINGENCY BY 28 DAYS: WAVE 2 -0.008��� -0.031���
(0.001) (0.002)
[0.000] [0.000]
LAGGED STRINGENCY BY 28 DAYS: WAVE 3 -0.028���
(0.002)
[0.000]
COUNTRIES 113 40 63 10
R2 0.76 0.75 0.76 0.81
COUNTRY FIXED EFFECTS Yes Yes Yes Yes
TIME TREND Yes Yes Yes Yes
LAGGED DEATHS CONTROL Yes Yes Yes Yes
Notes: All regressions coefficients are included in the table, followed by standard errors in parentheses and p-values in square brackets. Stars signify statistical
significance at conventional thresholds.
https://doi.org/10.1371/journal.pone.0253116.t001
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points. This means that a 10-point difference in SI would be expected to lead, four weeks later,
to 28 percentage point fewer deaths during the third wave. We further note a high R-squared
of .75 to .81 across all regressions, indicating that our estimation model fits the data well.
Because different groups of countries experienced one, two, or three waves of disease, it is not
possible to compare the magnitudes of the coefficients across all columns in Table 1. However,
the overall results clearly show an enduring relationship between policies and deaths across
countries and across waves.
We also include a series of robustness tests in the S2.1–S2.4 Tables in S1 File. These robust-
ness tests show analysis using subnational units for large heterogeneous countries such as the
United States and Brazil. Additional robustness tests include specific controls, such as GDP
hospital bed availability and comorbidities, testing and contract tracing policies, as well as
using an alternative index, the government response index. All robustness tests show similar
trends, with consistent relationship between more stringent NPIs and fewer deaths, and persis-
tent effects across multiple waves of the pandemic.
Discussion
Our data show that government responses do indeed have a statistically robust and substan-
tively significant relationship with deaths related to COVID-19. Moreover, this relationship
endures across multiple waves of disease. At the same time, the findings reveals that the effect
of NPIs has varied over time and across countries to some degree. This might be for a variety
of reasons: for example, perhaps vaccine rollouts coupled with government policy counter-
acted potential fatigue in adherence with policies, resulting in sustained effectiveness of gov-
ernment policies in reducing deaths. In this paper our aim is not to identify precise reasons for
differences in effectiveness across waves, which likely diverge across countries, but rather to
identify the first-order patterns in the effectiveness of NPIs over time. This motivates future
research into effectiveness of policies during specific waves of the pandemic.
Our study has several limitations. Like any policy intervention, the effect of the responses
we measured is likely to be highly contingent on local political and social contexts. For
instance, the state-by-state level response in the United States has been heterogeneous, while
our primary analysis is conducted at the national level (however, as S2.3 Table in S1 File
shows, these patterns also hold across subnational jurisdictions). Nor do we measure the extent
to which government interventions are successfully implemented. In addition, the relation-
ships reported do not account for potential confounders that might have otherwise reduced
deaths, such as seasonality, climate, or spontaneous behavioural change in response to chang-
ing risk perceptions or social norms in the population. While these factors have not yet been
fully established for COVID-19, if they are, they will need to be accounted for to more reliably
estimate the effect of government policies on growth in deaths. In spite of these limitations,
our approach offers a global and comprehensive view of governmental response to COVID-19
to date with the best information available. By measuring a range of indicators, composite
indices mitigate the possibility that any one indicator may be over- or mis-interpreted. By the
same token, composite measures also make strong assumptions about what kinds of informa-
tion are included. If the information left out is systematically correlated with the outcomes of
interest, or systematically under- or overvalued compared to other indicators, such composite
indices may introduce measurement bias.
Our results are in line with findings of changes in NPIs and the development of pandemics
over time. Multi-country analyses have found the implementation NPIs was significantly asso-
ciated with an overall reduction in COVID-19 incidence [61]. An analysis of the effect of five
policy responses on COVID-19 deaths in 11 European countries found a significant impact of
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interventions implemented several weeks before late March 2020, though these results were
strongly driven by the experiences of Spain and Italy [16]. These findings hold in single-coun-
try studies and those focusing on subnational regions. A modelling study finds that without
NPIs the number of COVID-19 cases would have been 51 to 125 folds higher in different cities
and provinces in China [66]. The NPIs implemented in New York City were estimated to have
reduced cases numbers by 72% and deaths by 76% [67]. While some studies shows the rela-
tionship between single NPI and the reduction in COVID-19 incidences or reproduction
number, others try to identify the more effective blends of NPI sub-categories [68–70]. How-
ever, researchers also find the synergistic benefits of implementing a suite of multiple NPIs,
which lends support to our approach of assessing the relationship between overall NPIs and
deaths [71, 72].
Apart from the general association between NPIs and the spread of disease, researchers
have also looked at how such relationships change over the course of previous pandemics.
For example, earlier stringency measures decreased death rates in the 1918–1919 influ-
enza pandemic by as much as 50% [73, 74]. That pandemic was characterised by three
waves, with second and third waves occurring only after the relaxation of the “main bat-
tery of NPIs” [43, 75]. More recently, researchers start to look at how the association
between NPIs and cases and deaths vary across different COVID-19 waves. A study inves-
tigating the performance of different NPIs across waves in 133 countries finds the most
effective NPI blends change from gathering restrictions, facial coverings and school clo-
sures to facial coverings, gathering restrictions and international travel restrictions in the
second wave. It concludes that the impact of NPIs had obvious spatiotemporal variations
across countries by waves before vaccine rollouts [76]. According to a studying on 114
subnational areas in 7 European countries, the combined effectiveness of 17 NPIs on
reducing local cases and deaths is still statistically significant, but the effect sizes in the
second wave were smaller relative to that in the first wave [33]. The global analysis of vary-
ing association between NPIs and COVID-19 deaths in our paper echoes these findings
and contributes to the emerging evidence base on how the relationship between NPIs and
the spread of COVID-19 varies or remains constant over time.
Going forward, it will be important to continue monitoring government responses as
the pandemic evolves. More granular analyses looking at the implementation and effec-
tiveness of national policies, the role of individual measures and various combinations of
policies, as well as the role of subnational governments or other social institutions can
contribute further to this line of investigation. Further work should seek to explain varia-
tion in the effectiveness of NPIs across countries, examining both cross-sectional and lon-
gitudinal factors. Of particular importance, researchers can examine the role of path
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